Altria Group Inc.: Barclays raises target price to $60 from $58
MO•Barclays raised its target price for Altria Group to $60 from $58.
Related News
Genfit plans Phase 2 trial of nangibotide in acute-on-chronic liver failure
GNFT•
Raymond James raises Merit Medical Systems target price to $104 from $100
MMSI•
KBW cuts Riot Platforms target price to $20 from $35
RIOT•
Borr Drilling updates on Prospector 5 rig incident
BORR•
Methanex Corporation: JPMorgan raises target price to $63 from $55
MEOH•